Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
Status:
Completed
Trial end date:
2017-08-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if adding dapagliflozin to insulin is a safe and
effective therapy to improve glycemic control in patients with type 1 diabetes.